Wikidata

(Q63336885)

English

Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients

clinical trial

In more languages

Statements

short name
CAMA-2 (English)
0 references
title
Phase III A Prospective, Longitudinal, Rater-blinded Single-arm Study to Evaluate Alemtuzumab as an Effective Treatment in Stabilizing Overall Neurocognitive Function in RRMS Subjects at Specified Timepoints (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
start time
May 2011
0 references
end time
December 2013
0 references
number of participants
30
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63336885&oldid=1857160196"